rapid-acting antidepressants

rapid-acting antidepressants

Positive Phase 3 Test of Rapid-Acting Oral Medicine for Postpartum Depression
An investigational medicine called zuranolone has generated significant, rapid, and enduring symptom reduction in women with postpartum depression . The... Read More
Positive Results in Trial Testing ‘Laughing Gas’ in Severely Depressed Treatment-Resistant Patients
Newly reported results of a small phase 2 clinical trial indicate the potential utility of using nitrous oxide treatments in... Read More
Remarkable Results in a Preliminary Clinical Test of a Rapid-Acting Antidepressant Treatment
Imagine a new treatment for people with major depression who have not responded to existing treatments—one that acts rapidly and... Read More
In a Surprising Clinical Trial, Ketamine’s Antidepressant Effects Lasted Longer
Carefully designed, exquisitely controlled experiments sometimes don't produce the result predicted in advance—the research “hypothesis” that is the starting point... Read More
Over Two Decades, 90 BBRF Grants Helped Build a Scientific Foundation for the First Rapid-Acting Antidepressants
In the spring of 2019, The Food and Drug Administration granted approval for two breakthrough medicines that act rapidly to... Read More